Drug Safety Issues: Psychotropic Drugs
In the first half of the twenty-first century, U.S. psychiatrists are prescribing the second generation neuroleptics—Zyprexa, Risperdal, Geodon, Seroquel, Abilfy—to coerce innocent children and the elderly into submission.
At the July 30, 2009 FDA advisory committee hearing, the only formal presentations at the meeting were a summary of the safety and efficacy data by the sponsor.
But FDA says keep taking the "medicines."
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage.
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
Inexplicably, the FDA has dragged its feet about adding a warning label to both tamoxefin and the antidepressants, Paxil, Prozac and Zoloft–despitethe unanimous recommendation of its own advisory panel in 2006.
This is a result of public awareness–thanks to information uncovered during litigation, by Sen. Charles Grassley’s investigative team, by whistleblowers, and the press!
The Japanes Ministry of Health, Labor and Welfare has investigated news reports about antidepressant users "who developed increased feelings of hostility or anxiety, and have even committed sudden acts of violence against others."
The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone :
The Patriot Ledger reports that Rebecca Riley’s psychiatrist, Dr. Kayoko Kifuji, is under criminal investigation by a grand jury.
"We’ve known this drug is a bad actor for a long time." Now it’s confirmed exposure to Depakote (valproate) in utero lowers children’s intelligence.
